An interactive map about institutional investors and their engagement in the stock market
Equity Distribution for PTC THERAPEUTICS Inc
| Ticker | PTCT |
| FIGI | BBG000QT15P7 |
| CUSIP | 69366J200 |
| Sector | Healthcare |
| Equity Type | Common Stock |
| No. Companies Holding this Equity | 186 / 2.7% |
| Percentage held by institutional investors | 100.0% |
About
PTC Therapeutics is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases. PTC acquired the Bio-e platform in 2019. Wikipedia